Ovarian Cancer
A team of researchers aimed to analyze the genetic expression and prognostic value of selenoprotein gene mutations.
Ovarian cancer patients value personalized follow-up care and reassurance.
Dr. David Gershenson discusses results from the first-ever low-grade serious ovarian cancer impact survey.
A large-scale UK trial of ovarian cancer screening was unable to reduce deaths from the disease, according to a study ...
A study recently found that a conventional carboplatin–paclitaxel doublet regimen was more effective than single-agent ...
Rachel N. Grisham, MD, Section Head, Ovarian Cancer and Director, Gynecologic Medical Oncology at Memorial Sloan ...
According to a new study, population-wide screening for genetic variants linked to hereditary breast and ovarian cancer ...
Women receiving fertility-sparing surgery (FFS) for borderline ovarian tumors were still able to conceive, according to ...
Advertisement
Expert Interviews on Oncology
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.